*Ecopipam is an investigational, selective D1 (dopamine) receptor antagonist targeting dopaminergic signaling in the brain’s ...

SHENZHEN, CHINA - Media OutReach Newswire - 3 October 2026 - Huawei hosted an international media roundtable today featuring ...

Wendel (Euronext: MF.FP) announces it finalized the sale of its stake in Stahl (excluding Muno) for an enterprise value of ...

Ecopipam is a first-in-class investigational therapy designed to block dopamine signaling at the D1 receptor. D1 receptor hypersensitivity may contribute to repetitive and compulsive behaviors ...

LONDON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Argentina has unveiled the details of its new Citizenship by Investment Program, marking a significant development in Latin America’s evolving residence and ...

Coalition seeks an effective and fair EU approach for responsible biometric travel to protect passenger choice, privacy and ...

CAPHRA reminds everyone that the Asia Forum on Nicotine (AFN26) will convene in Manila on 16 and 17 October 2026. No more ...

Trump Towers Hyderabad Will Feature Two 65-Storey Towers Rising Approximately 800 Feet, Connected by a State-of-the-Art ...

Ireland Launch Demonstrates a Scalable Approach to Branded Calling Across Vodafone Markets. Key Takeaways *First Orion and ...

AI platform scores every server, storage and network device from 0 to 100, giving IT teams OEM-level data to decide whether ...

After more than 425,000 autonomous investigations in Early Access, Elevate turns alerts into audit-ready verdicts that ...

As Mr. Mallon joins the Board, Brendan May will step down. TMC thanks Mr. May for his important contributions over the past ...